Kết quả tìm kiếm

[Jakarta, Indonesia] - [July 15, 2025] - Medscore, a leading provider of technology - driven patient access solutions, is proud to announce its official expansion into the Indonesian market, marking a strategic milestone in the company’s Asia-Pacific growth journey. Following extensive research, solution development and ongoing technological innovation, Medscore continues its mission to build a more efficient and inclusive healthcare ecosystem, where advanced technology serves as the bridge between treatment and access. Indonesia: A Strategic Market in Asia-Pacific With a population of over 280 million and a rapidly evolving healthcare system, Indonesia faces a critical challenge: how to ensure that patients do not have to interrupt their treatment due to the burden of medical expenses. This is precisely where Medscore is uniquely positioned to lead meaningful change. By implementing transparent, automated technology solutions, Medscore enables accurate patient assessment, appropriate support delivery and timely access to treatment contributing to a more equitable and responsive healthcare delivery system. Driving Access Through Advanced Technology Medscore leverages automated scoring technology to support global pharmaceutical partners operating in emerging markets. This advanced solution enables precise evaluation of patients’ ability to access treatment, ensuring that assistance is delivered in a manner that is fair, appropriate and transparent. By optimizing the delivery of care, the platform streamlines operations across the treatment journey. Through the assessment of patients’ ability to access care and determining appropriate levels of support, Medscore empowers its partners to reach thousands of underserved patients efficiently, reducing operational burden while enhancing overall impact. A Long-Term Commitment to Asia-Pacific From Vietnam to the Philippines and now Indonesia, Medscore continues to strengthen its presence across Asia-Pacific, driven by a vision to help build a more equitable and resilient healthcare landscape. At the core of this expansion is a steadfast commitment to bridging the divide between patients in need and the essential treatments that can save their lives, especially in regions where access to care remains limited and uneven. “As we expand our reach, we remain grounded in our belief that technology should serve humanity,” said Olivia, Chief Executive Officer of Medscore.   “Our goal is a future in which every patient, no matter where they live, can receive timely, appropriate and transparent access to the care they deserve.” Ms. Olivia, CEO of Medscore, present in Indonesia to kick off our new chapter Laying the Groundwork for Strategic Partnerships in Indonesia Medscore is actively establishing collaborations with leading pharmaceutical partners in Indonesia to launch targeted access programs in the near future. This expansion reflects the company’s long-term vision to co-create solutions with local stakeholders and improve health outcomes for patients across the region.

​ [Hanoi, Vietnam] – [December 28, 2023] – MedScore, a leading software provider of patient access solutions, today received approval from the Vietnam Ministry of Health for its innovative cancer patient access programs offered by global pharmaceutical sponsor company.   The program leverages MedScore's innovative scoring solution (Means Testing) with geo-location intelligence and banking-level underwriting to digitally assess patients across emerging markets, ensuring they receive the critical treatment they need. ​ MedScore empowers sponsor companies to effectively reach their underserved patients in 45+ top tiers hospitals (private and public) from all over the country. By utilizing AI-powered scoring technology, MedScore can efficiently evaluate thousands of patients, streamlining the process and granting them access to breakthrough immunology treatment. ​ “ Our mission is to bridge the gap between patients in need and life-saving medications ,” said Olivia, CEO of MedScore. “With traditional low-digital methods often proving cumbersome and time-consuming, our technology offers a faster, more scalable solution specifically designed for the unique challenges of emerging markets.” ​ MedScore's comprehensive solution offers several key benefits: Enhanced Efficiency : AI-powered assessments streamline the patient evaluation process, enabling pharmaceutical companies to reach a wider pool of qualified patients. Improved Accuracy : Geo-location intelligence and banking-level underwriting ensure accurate patient selection for access programs. Scalability : MedScore's technology can be seamlessly deployed across multiple countries and regions, maximizing program reach. Faster Access to Treatment : By expediting the patient evaluation process, MedScore helps ensure patients receive timely access to critical treatment.

[Singapore] – [August 1st, 2023] – Medscore , a pioneering healthcare technology company, is committed to transforming the landscape of cancer care in emerging markets. By leveraging advanced means testing software, Medscore empowers patients with cancer and rare diseases to access critical, life-saving treatments that were once out of reach due to affordability challenges ​ The Critical Role of Means Testing to revolutionize access to break-through treatment in emerging markets Means testing is a crucial process that assesses a patient's financial eligibility for subsidized or free medication. In emerging markets, where universal healthcare coverage are limited and patient out-of-pocket expense is high (more than 50%), means testing ensures that essential treatments reach those who need them most. However, traditional methods of means testing can be time-consuming, bureaucratic, and often result in delays or denials of treatment. Medscore’s Innovative Solution Medscore addresses these challenges by providing a cutting-edge software-as-a-service (SaaS) solution that streamlines the means testing process. Our platform leverages advanced algorithms and data analytics to quickly and accurately determine a patient's eligibility for subsidized or free medication. This significantly reduces (10x compared to industry standard) the time it takes for patients to access life-saving treatments, improving their chances of survival and quality of life.  Currently, all means testing process is 100% digital and the fastest rate ever recorded is instant thanks to technology integration and partnership ecosystem enablers such as government tech.. Key Benefits of Medscore: * Accelerated Patient Access : Streamlined means testing leads to faster treatment initiation. * Data-Driven Decision Making:  Real-time analytics empower healthcare providers to make informed decisions. * Localization at scale:  Tech-driven platform which enables any local patient access program regionally, be it language or local nuances in income structure.  About Medscore Medscore is a team of healthcare experts and insurtech technologists dedicated to improving patient outcomes in emerging markets. Our mission is to make life-saving treatments accessible to all, regardless of their financial circumstances. By leveraging technology and local expertise, Medscore is revolutionizing the way healthcare is delivered in these regions.  Media Contact: Med.holdings Communications apac@medscore.io

Medscore and MedAccess Broaden Asia Pacific Presence with Comprehensive Program Management Solutions [Jakarta, Indonesia] – [April 25, 2024] – MedScore, a leading tech provider of patient access solutions, is set to launch a nationwide patient access program in collaboration with a global sponsor company. The program will be rolled out in phases, ensuring a comprehensive digital transformation, encompassing enrollment, means testing, payment, and treatment onboarding.   This initiative utilizes advanced technology solutions like MedScore and MedAccess to offer a complete end-to-end digital experience for underserved patients and their caregivers. ​ In Southeast Asia, MedScore has enabled sponsor companies to effectively reach underserved patients in Vietnam and the Philippines, with official government endorsement, such as from the Vietnam Ministry of Health in 2023. ​ “We believe in healthcare digital transformation and equity,” said Olivia, CEO of MedScore. “Our technology is both scalable and localizable, specifically for the dynamic challenges of emerging markets.” MedScore's comprehensive solution offers several key benefits: Enhanced Efficiency : AI-powered assessments streamline the patient evaluation process, enabling pharmaceutical companies to reach a wider pool of qualified patients. Improved Accuracy : Geo-location intelligence and banking-level underwriting ensure accurate patient selection for access programs. Scalability : MedScore's technology can be seamlessly deployed across multiple countries and regions, maximizing program reach. Faster Access to Treatment : By expediting the patient evaluation process, MedScore helps ensure patients receive timely access to critical treatment. Media Contact: Med.holdings  Communications apac@medscore.io

Medscore Expands Global Reach, Bringing Hope to Filipino Cancer Patients with technology. [Manila, Philippines] – [November 25, 2024] – MedScore, a leading Tech provider of patient access solutions, launched innovative cancer patient access programs offered by global pharmaceutical company.   The program leverages MedScore's innovative affordability scoring solutions (means testing) with geo-location intelligence and banking-level underwriting to digitally assess patients across emerging markets, ensuring they receive the critical treatment they need. ​ MedScore empowers pharmaceutical companies to effectively reach their underserved patients in Vietnam and the Philippines. By utilizing AI-powered scoring technology, MedScore can efficiently evaluate thousands of patients, streamlining the process and granting them access to breakthrough immunology treatment. ​ “Our mission is to bridge the gap between patients in need and life-saving medications,” said Olivia, CEO of MedScore. “With traditional low-digital methods often proving cumbersome and time-consuming, our technology offers a faster, more scalable solution specifically designed for the unique challenges of emerging markets.” MedScore's comprehensive solution offers several key benefits: Enhanced Efficiency : AI-powered assessments streamline the patient evaluation process, enabling pharmaceutical companies to reach a wider pool of qualified patients. Improved Accuracy : Geo-location intelligence and banking-level underwriting ensure accurate patient selection for access programs. Scalability : MedScore's technology can be seamlessly deployed across multiple countries and regions, maximizing program reach. Faster Access to Treatment : By expediting the patient evaluation process, MedScore helps ensure patients receive timely access to critical treatment. Media Contact: Med.holdings  Communications apac@medscore.io

[Singapore] - [November, 2024] – Medscore, a pioneering healthcare technology company, is scheduled to intergrate its innovative means testing software with Singpass, Singapore’s national digital identity platform. ​ This integration empowers healthcare providers to instantly verify patient identity and conduct means testing, streamlining the process of accessing critical medications for underserved patients with cancer and rare diseases. Medscore’s mission is to accelerate drug access for patients in emerging markets by simplifying the complex process of means testing. By leveraging advanced technology and deep healthcare expertise, Medscore empowers healthcare providers to quickly assess patient eligibility for financial assistance programs, ensuring that life-saving medications reach those who need them most. Key Benefits of the Singpass Integration: * Instant Patient Verification:  Real-time verification of patient identity, eliminating manual paperwork and reducing administrative burdens. * Streamlined Means Testing:  Automated assessment of patient financial eligibility, accelerating the approval process. * Enhanced Patient Experience:  A seamless and efficient experience for patients seeking access to vital medications. “We are thrilled to integrate with Singpass, a Singapore GovTech digital identity platform. This developement marks a significant step forward in our mission to improve patient access to life-saving medications,” said Olivia Nguyen, Group CEO at Medscore. “By leveraging technology and simplifying the process, we can empower healthcare providers to focus on delivering quality care and ultimately save lives.” About Medscore Medscore is a healthcare technology company dedicated to improving patient access to essential medications in emerging markets. Our innovative means testing software empowers healthcare providers to efficiently assess patient eligibility for financial assistance programs, ensuring that life-saving treatments reach those who need them most. With a focus on technology, healthcare expertise, and local market knowledge, Medscore is driving positive change in the global healthcare landscape. Media Contact: Med.holdings Communications apac@medscore.io